CK Life Sciences International (Holdings), Inc.
Total Valuation
USDAs of June 30, 2026, CK Life Sciences International Holdings Inc. carries a market capitalization of 859.97M, placing it among publicly traded companies globally. Its enterprise value stands at 1.68B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 859.97M |
| Enterprise Value | 1.68B |
Share Statistics
As of June 30, 2026, CK Life Sciences International Holdings Inc. has 9.61B shares outstanding.
| Shares Outstanding | 9.61B |
Valuation Ratios
These figures are as of June 30, 2026.
| PB Ratio | 1.71 |
| P/TBV Ratio | 11.81 |
Financial Position
As of June 30, 2026, CK Life Sciences International Holdings Inc. maintains a current ratio of 0.91, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.91 |
| Quick Ratio | 0.16 |
| Debt / Equity | 167.02 |
Financial Efficiency
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 1,920.00 |
Balance Sheet
USDAs of June 30, 2026, CK Life Sciences International Holdings Inc. holds 68.31M in cash and equivalents against 871.25M in total debt, resulting in a net debt position of 719.73M. Total book value stands at 503.38M, with working capital of -37.18M providing operational flexibility.
| Cash & Cash Equivalents | 68.31M |
| Total Debt | 871.25M |
| Net Debt | 719.73M |
| Equity (Book Value) | 503.38M |
| Book Value Per Share | 0.05 |
| Working Capital | -37.18M |
Stock Splits
CK Life Sciences International Holdings Inc.'s most recent stock split took place on April 6, 2006.
| Last Split Date | 4/6/2006 |